Bellevue F.(L)-B.He.Strategy U2 EUR/  LU2334253387  /

Fonds
NAV2024-04-15 Chg.-0.8800 Type of yield Investment Focus Investment company
123.0500EUR -0.71% reinvestment Equity Waystone M.Co.(Lux) 
     
Chart for Bellevue F.(L)-B.He.Strategy U2 EUR
  Name   ISIN Performance Volatility Sharpe ratio
1. HSBC GIF-Gl.Eq.Sust.Healthcare ZC LU2324357552 +17.06% 9.77% 1.36
2. BGF World Healthscience I2 JPY LU2263536315 +19.51% 13.76% 1.14
3. MEDICAL BioHealth EUR IX LU1152054125 +29.99% 23.73% 1.10
4. MEDICAL BioHealth EUR E LU1783158469 +30.48% 24.39% 1.09
5. MEDICAL BioHealth EUR I LU0294851513 +29.63% 23.74% 1.09
6. MEDICAL BioHealth EUR LU0119891520 +29.10% 23.57% 1.07
7. JPM-Global Healthcare Fd.X(acc)JPY LU0942618132 +19.65% 14.10% 1.12
8. PolarCap.Fds.plc-Healthc.Opp.F.I EUR D. IE00B3K83P04 +14.07% 13.13% 0.78
9. HSBC GIF-Gl.Eq.Sust.Healthcare XC LU2350756875 +17.22% 12.63% 1.06
10. PolarCap.Fds.plc-Healthc.Opp.F.R EUR D. IE00B3NLSS43 +13.50% 13.20% 0.73
...
219. Bellevue F.(L)-B.He.Strategy U2 EUR LU2334253387 +1.13% 9.54% -0.29